Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
16-30 of 422
First-Line Treatment Considerations in Advanced Urothelial Carcinoma
Project Oncology®First-Line Treatment Considerations in Advanced Urothelial Carcinoma
Guru P. Sonpavde, MD
Can AI Imaging Improve Risk Stratification in Upper Tract Urothelial Carcinoma?
Project Oncology®Can AI Imaging Improve Risk Stratification in Upper Tract Urothelial Carcinoma?
Real-World Sacituzumab Govitecan Reinforces Benefit in mTNBC
On the Frontlines of Metastatic Breast CancerReal-World Sacituzumab Govitecan Reinforces Benefit in mTNBC
Ryan Quigley
Urine RNA Panel Supports Less Invasive Bladder Cancer Surveillance
Project Oncology®Urine RNA Panel Supports Less Invasive Bladder Cancer Surveillance
Rationale of Emerging Antigen-Directed Strategies in Frontline ES-SCLC
MinuteCE®Rationale of Emerging Antigen-Directed Strategies in Frontline ES-SCLC
Neal Ready, MD, PhD
Clinical Evidence on Emerging Antigen-Directed Strategies in ES-SCLC
MinuteCE®Clinical Evidence on Emerging Antigen-Directed Strategies in ES-SCLC
Ticiana Leal, MD
- advertisement
The Survival Ceiling in ES-SCLC: Why Checkpoint Blockade Alone Is Not Enough
MinuteCE®The Survival Ceiling in ES-SCLC: Why Checkpoint Blockade Alone Is Not Enough
Neal Ready, MD, PhD
On the Horizon: Emerging Antigen-Directed Strategies Across Disease Stage
MinuteCE®On the Horizon: Emerging Antigen-Directed Strategies Across Disease Stage
Ticiana Leal, MD
Neal Ready, MD, PhD
Ticiana Leal, MD
Exploring Treatment Strategies in epNEC: The Emerging Role of DLL3
Project Oncology®Exploring Treatment Strategies in epNEC: The Emerging Role of DLL3
Charles Turck, PharmD, BCPS, BCCCP
Jason Starr, DO
From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
MinuteCE®From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
Aditya Bardia, MD, MPH, FASCO
Erica L. Mayer, MD, MPH
Cracking the Code: Risk Stratification Guidelines to Identify High-Risk Patients
MinuteCE®Cracking the Code: Risk Stratification Guidelines to Identify High-Risk Patients
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
- advertisement
Precision in Practice—Bringing Targeted Therapy to mHSPC
MinuteCE®Precision in Practice—Bringing Targeted Therapy to mHSPC
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
ADT Intensification in Biochemically Recurrent Prostate Cancer: When to Act
MinuteCE®ADT Intensification in Biochemically Recurrent Prostate Cancer: When to Act
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
The Power of Timing: Therapies That Change Outcomes
MinuteCE®The Power of Timing: Therapies That Change Outcomes
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
